In the context of EGFR-mutated NSCLC, a study that analyzed 109 patients with lung adenocarcinoma showed that AXL expression correlated with lymph node metastasis and was more frequently detected in EGFR-mutated compared to EGFR wild-type lung tumors [193]. This evidence concerns the gene AXL and non-small cell lung carcinoma.